INT60137

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.17
First Reported 1993
Last Reported 1997
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 0.93
Pain Relevance 1.43

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (SST) extracellular region (SST) cell-cell signaling (SST)
SST (Homo sapiens)
Pain Link Frequency Relevance Heat
Somatostatin 8 100.00 Very High Very High Very High
Enkephalin 9 97.52 Very High Very High Very High
antagonist 1 93.04 High High
opiate 1 92.24 High High
Neuropeptide 6 90.68 High High
Potency 1 78.72 Quite High
Pain 3 60.92 Quite High
palliative 1 46.36 Quite Low
Disease Link Frequency Relevance Heat
Lymphatic System Cancer 1 86.04 High High
Carcinoma 1 83.56 Quite High
Breast Cancer 6 81.80 Quite High
Cancer 3 76.04 Quite High
Immunotherapy Of Cancer 1 75.00 Quite High
Reprotox - General 1 1 67.36 Quite High
Pain 3 60.92 Quite High
Metastasis 2 59.12 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Phosphoramidon and DL-thiorphan similarly inhibited the degradation of GRP-10 (mean of 35% inhibition), somatostatin-14 (57%) and the aminopeptidase-resistant analogue, [D-Ala2][Leu5]enkephalin (75%).
Negative_regulation (inhibited) of Protein_catabolism (degradation) of somatostatin-14 associated with somatostatin and enkephalin
1) Confidence 0.17 Published 1993 Journal Exp. Physiol. Section Abstract Doc Link 8448012 Disease Relevance 0 Pain Relevance 1.06
Both gentisic acid and ascorbic acid are present in the Re-188-HEDP and Re-188-RC-160 formulations, and have been found to also significantly reduce radiolytic degradation of the somatostatin peptide analogues, and may have general application in the stabilization of Re-188-labeled radio-pharmaceuticals.
Negative_regulation (reduce) of Protein_catabolism (degradation) of somatostatin peptide associated with somatostatin
2) Confidence 0.06 Published 1997 Journal Anticancer Res. Section Abstract Doc Link 9179235 Disease Relevance 0.93 Pain Relevance 0.37

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox